YAP1 and cancer: Given that the MVA‐GGPP axis is involved in cancer progression by activating the transcriptional co‐regulator YAP as a Hippo pathway downstream effector (Zhao et al, 2008; Zhang et al, 2009; Sorrentino et al, 2014; Wang et al, 2014; Mi et al, 2015), we investigated the relevance of the YAP signaling pathway in crizotinib resistance.